Accountability in Pharmaceutical Practices

This chapter explores the accountability of pharmaceutical companies, specifically addressing the case of Vioxx and the consequences of COVID-19 medical decisions. It critiques vaccine mandates and the impact of ventilator use on mortality during the pandemic while reflecting on the socio-economic repercussions of lockdowns. The discussion emphasizes the neglect of critical health messages, particularly concerning vitamin D, and questions the efficacy of public health policies implemented during this time.